MaxCyte (MXCT) Competitors

Herald (LON:HRI) and MaxCyte (LON:MXCT) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings.

Which has better valuation and earnings, HRI or MXCT?

Herald has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Herald, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Herald	£162.63M	6.30	£175.20M	£346.54	5.86
MaxCyte	£57.52M	4.91	-£45.08M	-£27.29	-7.84

Which has more volatility and risk, HRI or MXCT?

Herald has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500.

Does the media prefer HRI or MXCT?

In the previous week, Herald had 1 more articles in the media than MaxCyte. MarketBeat recorded 1 mentions for Herald and 0 mentions for MaxCyte. MaxCyte's average media sentiment score of 0.00 beat Herald's score of -1.15 indicating that MaxCyte is being referred to more favorably in the news media.

Company	Overall Sentiment
Herald	Negative
MaxCyte	Neutral

Do institutionals & insiders have more ownership in HRI or MXCT?

31.8% of Herald shares are held by institutional investors. Comparatively, 70.5% of MaxCyte shares are held by institutional investors. 5.4% of Herald shares are held by insiders. Comparatively, 1.5% of MaxCyte shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is HRI or MXCT more profitable?

Herald has a net margin of 107.72% compared to MaxCyte's net margin of -78.37%. Herald's return on equity of 14.78% beat MaxCyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Herald	107.72%	14.78%	9.22%
MaxCyte	-78.37%	-16.01%	-11.07%

Does the MarketBeat Community believe in HRI or MXCT?

MaxCyte received 50 more outperform votes than Herald when rated by MarketBeat users. Likewise, 68.92% of users gave MaxCyte an outperform vote while only 67.76% of users gave Herald an outperform vote.

Company	Underperform	Outperform
Herald	Outperform Votes 103 67.76%	Underperform Votes 49 32.24%
MaxCyte	Outperform Votes 153 68.92%	Underperform Votes 69 31.08%

Summary

Herald beats MaxCyte on 10 of the 15 factors compared between the two stocks.